(Q42278956)

19 October 2017

Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population (English)

1 reference

19 October 2017

0 references

0 references

hepatocellular carcinoma

1 reference

1 reference

Bhupesh Singla

6

0 references

author name string

Balkrishan Sharma

1

1 reference

19 October 2017

Radhika Srinivasan

2

1 reference

19 October 2017

Yogesh Kumar Chawla

3

1 reference

19 October 2017

Shweta Kapil

4

1 reference

19 October 2017

Nitin Saini

5

1 reference

19 October 2017

Anuradha Chakraborthy

7

1 reference

19 October 2017

Naveen Kalra

8

1 reference

19 October 2017

Ajay Duseja

9

1 reference

19 October 2017

Radha Krishan Dhiman

10

1 reference

19 October 2017

language of work or name

1 reference

13 July 2010

1 reference

19 October 2017

Hepatology international

1 reference

19 October 2017

4

1 reference

19 October 2017

3

1 reference

19 October 2017

569-576

1 reference

https://scigraph.springernature.com/pub.10.1007/s12072-010-9186-2

19 October 2017

0 references

cites work

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Hepatocellular carcinoma: epidemiology, risk factors, and screening

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Randomized controlled trial of screening for hepatocellular carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Estimating the world cancer burden: Globocan 2000.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Management of hepatitis B: 2000--summary of a workshop

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Long course and prognostic factors of virus-induced cirrhosis of the liver

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Diagnosis and follow-up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong Kong

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940002

The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin

17 August 2018

1 reference

12 December 2020

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group

1 reference

12 December 2020

Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function

1 reference

12 December 2020

Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma

1 reference

12 December 2020

Prediction of Invasive Activities in Hepatocellular Carcinomas with Special Reference to -Fetoprotein and Des- -carboxyprothrombin

1 reference

12 December 2020

Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients

1 reference

12 December 2020

Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma

1 reference

12 December 2020

Early recognition of hepatocellular carcinoma

1 reference

12 December 2020

Screening for hepatocellular carcinoma

1 reference

12 December 2020

CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation

1 reference

12 December 2020

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

12 December 2020

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

12 December 2020

Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes

1 reference

12 December 2020

The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients

1 reference

12 December 2020

A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma

1 reference

12 December 2020

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein

1 reference

12 December 2020

10.1007/S12072-010-9186-2

Identifiers

DOI

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

21063479

1 reference